Ivermectin For Covid-19 Real-Time Meta Analysis Of 67 Studies
Background: Ivermectin became a popular choice for COVID-19 treatment among clinicians and the public following encouraging results from pre-print trials and in vitro studies. Early reviews recommended the use of ivermectin based largely on non-peer-reviewed evidence, which may not be robust. This systematic review and meta-analysis assessed the efficacy and safety of.
আপনি যদি কৌতুহলী সম্পর্কে জানতে হয় Ivmmeta.comর্যাংকিং.
Home COVID-19 treatment studies for Ivermectin Select treatment Global adoption: 45% IVERMECTIN ADOPTION MINIMAL COVID-19 ISOLATED USE SOME REGIONS MIXED USAGE MANY REGIONS COUNTR
Hence, we conducted this systematic review and meta-analysis to assess the currently available data on the therapeutic potential of ivermectin for the treatment of COVID-19 as add on therapy. A total of 629 patients were included in the 4 studies and all were COVID-19 RT-PCR positive.